Clinical Characteristics of Autoimmune Gastroparesis and Response to Immunomodulation
In this retrospective analysis of a small cohort of patients with AGID, IVIG therapy was associated with symptom improvement, especially in those who were GAD+. Randomized, placebo-controlled trials are needed to understand the effectiveness of IVIG in treating AGID.
Authors
- Madison L. Simons (ORCID: https://orcid.org/0000-0002-5042-2725)
- Anthony J Lembo (ORCID: https://orcid.org/0000-0002-4479-1188)
- J. Trig Brown
- Jack Loesch (ORCID: https://orcid.org/0009-0005-4956-1612)
- Eyad Hamza
- Michael C. Cline
Institutions
- Cleveland Clinic (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1097/mcg.0000000000002254
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00